Economics and financing of vaccines for diarrheal diseases

Sarah M. Bartsch, Bruce Y. Lee

Research output: Contribution to journalReview articlepeer-review

8 Scopus citations


The considerable burden of infectious disease-caused diarrhea around the world has motivated the continuing development of a number of vaccine candidates over the past several decades with some reaching the market. As with all major public health interventions, understanding the economics and financing of vaccines against diarrheal diseases is essential to their development and implementation. This review focuses on each of the major infectious pathogens that commonly cause diarrhea, the current understanding of their economic burden, the status of vaccine development, and existing economic evaluations of the vaccines. While the literature on the economics and financing of vaccines against diarrhea diseases is growing, there is considerable room for more inquiry. Substantial gaps exist for many pathogens, circumstances, and effects. Economics and financing studies are integral to vaccine development and implementation.

Original languageEnglish (US)
Pages (from-to)1568-1581
Number of pages14
JournalHuman Vaccines and Immunotherapeutics
Issue number6
StatePublished - Jun 2014
Externally publishedYes


  • Burden
  • Cost-effectiveness
  • Diarrheal diseases
  • Economics
  • Gastroenteritis
  • Vaccines

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Pharmacology


Dive into the research topics of 'Economics and financing of vaccines for diarrheal diseases'. Together they form a unique fingerprint.

Cite this